News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Galectin Therapeutics Chairman Discusses Details of Fast Track Designation Today at 11 A.M.


8/16/2013 9:59:33 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ORLANDO, Fla., Aug. 16, 2013 (GLOBE NEWSWIRE) -- RedChip Companies, Inc. ("RedChip"), an international small-cap research, investor relations, and financial media company, today announced that Jim Czirr, executive chairman of Galectin Therapeutics (Nasdaq:GALT), a leading developer of therapeutics that target galectin proteins, will appear in an interview today on RedChip's Internet TV platform at 11:00 a.m. Eastern time. The interview will stream at http://www.redchip.com.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES